LIDDS: NanoZolid® with immune-stimulating agent demonstrates significant efficacy – GlobeNewswire (press release)
|
LIDDS: NanoZolid® with immune-stimulating agent demonstrates significant efficacy
GlobeNewswire (press release) LIDDS has successfully completed the first steps in one of its projects assessing the feasibility of using the NanoZolid® drug delivery technology for intratumoral immunotherapy with positive results. In one of LIDDS immune-oncology projects, an immune … |
